Two‐Part Phase 1 Study to Evaluate the Taste Profile of Novel Belumosudil Oral Suspensions and Assess the Relative Bioavailability and Food Effect of the Selected Belumosudil Oral Suspension Compared With Oral Tablet Reference in Healthy Male Participants

Documenti analoghi

• Taste Profile and Relative Bioavailability of Tovorafenib Powder for Oral Suspension and Food Effect of the Tovorafenib Tablet in Healthy Participants
  di: Yang Zhang, et al.
  Pubblicazione: (2025)
• Pharmacokinetics of Belumosudil and Its Metabolites in Individuals With Hepatic Impairment
  di: Olivier Schueller, et al.
  Pubblicazione: (2025)
• In Vitro and Clinical Evaluations of UGT1A1‐, P‐gp‐, OATP1B1‐, and BCRP‐Mediated Drug–Drug Interactions of Belumosudil, a Potent ROCK2 Inhibitor
  di: Olivier Schueller, et al.
  Pubblicazione: (2025)
• Pharmacokinetics of Nitazoxanide Dry Suspensions After Single Oral Doses in Healthy Subjects: Food Effects Evaluation and Bioequivalence Study
  di: Chenning Zhang, et al.
  Pubblicazione: (2024)
• A Phase 1, Open‐Label, Randomized, Two‐Part Study in Healthy Adult Volunteers to Evaluate the Bioavailability of the Maribavir Powder for Oral Suspension, as Well as Food Effect and Impact of Rabeprazole
  di: Olivia Campagne, et al.
  Pubblicazione: (2024)